drug · small molecule
patient view →tivozanib
Phase 2updated 2mo agoby Kyowa Kirin Co Ltd🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for renal cell carcinoma and neoplasm and 10 investigational indications.
indications
indications
Diabetic Macular Edema
targets
Platelet-derived growth factor receptor betaVascular endothelial growth factor receptorMast/stem cell growth factor receptor Kit
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that